Company: PTPI
Filing Date: 2025-02-14
Form Type: S-1/A
Source: 0001410578-25-000137
Chunk: 292

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-1/A
Chunk 292
---
 SEC on November 13, 2024).                                                                                  |
| 3.10    | ​ | Certificate of Amendment to the Certificate of Designations of Series A Convertible Preferred Stock of Petros Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on January 24, 2025).                                                                                      |

| 3.11** | ​ | Certificate of Designations of Series B Convertible Preferred Stock. |

| 4.1 
 4.2 |     | Specimen Stock Certificate evidencing shares of Common Stock (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-4 filed on October 28, 2020). 
 Description of Capital Stock (incorporated by reference to Exhibit 4.4 to the Company’s Annual Report on Form 10-K filed on April 1, 2024).                                            |
|:----|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.3 |     | Form of Investor Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 15, 2021).                                |
| 4.4 |     | Form of Investor Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 1, 2021).                                |
| 4.5 |     | Form of Investor Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 27, 2021).                               |
| 4.6 |     | Form of Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on July 13, 2023).                                                         |

| 4.7* | ​ | Form of Series A Warrant. |
| 4.8* | ​ | Form of Series B Warrant. |

II-5

| 4.9** | ​ | Form of Pre-Funded Warrant.       |
| 5.1*  | ​ | Opinion of Haynes and Boone, LLP. |

| 10.1   
 10.2+  |   | Registration Rights Agreement, dated as